Videos

Kathryn H. Schmitz, PhD, MPH, professor of Public Health Sciences and associate director of Population Sciences at the Penn State Cancer Institute, discusses what researchers already know regarding diet and exercise and breast cancer, and what questions are yet to be answered.

Erica Bell, PhD, assistant professor of Radiation Oncology at The Ohio State University, discusses prognostic factors for patients diagnosed with grade 2 gliomas.

Melisa Wong, MD, Oncology Chief Fellow, Hematology/Oncology at the University of California San Francisco, discusses differences among age groups in the treatment of non–small cell lung cancer (NSCLC).

Debu Tripathy, MD, chair of the Department of Breast Medical Oncology at University of Texas MD Anderson Cancer Center, discusses the potential for using breast cancer tumor DNA to make treatment decisions.

Olga Ivanov, MD, breast cancer surgeon at the Florida Hospital Cancer Institute, discusses sexual difficulties women who have had risk-reducing cancer surgery face.

​Nickhill Bhakta, MD, fellow at St. Jude Children’s Research Hospital, discusses disease burden on adult survivors of pediatric cancer.

Heather E. Wheeler, assistant professor of Biology and Computer Science at Loyola University Chicago, discusses genetic factors that may lead to hearing loss in patients with testicular cancer who are on cisplatin.

Celestia S. Higano, MD, of the Seattle Cancer Care Alliance, discusses sexual health services that are available to survivors of prostate cancer.

Mary McCabe, RN, MA, director of the Cancer Survivorship Center at Memorial Sloan Kettering (MSK) Cancer Center, discusses how nurse practitioners are becoming increasingly important in survivorship care for patients who are finished with their cancer treatment.

Harpreet Singh of the FDA discusses how clinical trial populations are not always reflective of the population of patients who eventually end up getting treated by the therapies.

Carlos Rodriguez-Galindo, MD, chair of the Department of Global Pediatric Medicine and director of the International Outreach Program at St. Jude Children’s Research Hospital, and chair of the rare tumor committee at the Children’s Oncology Group, discusses treating rare pediatric cancers.

​Grant Williams, MD, clinical instructor and research fellow at the University of North Carolina, Chapel Hill, discusses the impact the losing skeletal muscle mass has on elderly patients with cancer.

Alan B. Astrow, MD, chief of hematology and medical oncology at New York Methodist Hospital, discusses the importance of approaching spirituality in the oncology setting.

Nina Kadan-Lottick, MD, associate professor of Pediatrics (Hematology/Oncology and medical director of the HEROES program at Yale School of Medicine, discusses ways to improve survivorship care plans.

James L. Klosky, PhD, director or psychological services and cancer survivorship, St. Jude Children’s Research Hospital, discusses HPV-related complications, including cancer, for survivors of childhood cancer.

Emily Johnston, MD, fellow at Lucile Packard Children’s Hospital Stanford, discusses the differences between end-of-life care in adolescent and young adult (AYA) patients and older patients with cancer.

Ian R. Kleckner, PhD, Research Assistant Professor at University of Rochester Medical Center, discusses the benefits of exercise for patients with chemotherapy-induced peripheral neuropathy (CIPN).

Jennifer Levine, MD, Columbia University Medical Center, discusses the effects of early menopause on survivors of childhood cancer.

Ishwaria Mohan Subbiah, MD, of MD Anderson Cancer Center, discusses the importance of elderly patients enrolling in clinical trials. Ishwaria Mohan Subbiah, MD, MD Anderson Cancer Center, discusses the importance of elderly patients enrolling in clinical trials.

Halle Moore, MD, medical oncologist, Cleveland Clinic, discusses survivorship issues and symptoms that breast cancer survivors face.

Daniela Delbeau, RN, clinical research nurse coordinator at the Perlmutter Cancer Center at NYU Langone Medical Center, discusses how individuals react differently to treatment.

Alyson Moadel, PhD, director of psychosocial oncology, Albert Einstein College of Medicine, Montefiore Medical Center, discusses partner-related side effects of prostate cancer.

Michael Birrer, MD, PhD, Harvard Medical School, discusses the importance of personalized care for ovarian cancer.

Ryan Nipp, MD, Massachusetts General Hospital, discusses the correlation between symptom burden and length of hospital stay for patients with cancer.

Claire Friedman, MD, Memorial Sloan Kettering Cancer Center, discusses the promise of immunotherapy for elderly patients with melanoma.

Tara Sanft, MD, Yale Cancer Center, discusses VEGF as a possible link between diabetes and cancer.